Success Metrics

Clinical Success Rate
76.6%

Based on 36 completed trials

Completion Rate
77%(36/47)
Active Trials
20(20%)
Results Posted
36%(13 trials)
Terminated
11(11%)

Phase Distribution

Ph phase_2
5
5%
Ph early_phase_1
3
3%
Ph phase_4
1
1%
Ph phase_1
3
3%
Ph not_applicable
52
52%

Phase Distribution

6

Early Stage

5

Mid Stage

1

Late Stage

Phase Distribution64 total trials
Early Phase 1First-in-human
3(4.7%)
Phase 1Safety & dosage
3(4.7%)
Phase 2Efficacy & side effects
5(7.8%)
Phase 4Post-market surveillance
1(1.6%)
N/ANon-phased studies
52(81.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

67.9%

36 of 53 finished

Non-Completion Rate

32.1%

17 ended early

Currently Active

20

trials recruiting

Total Trials

100

all time

Status Distribution
Active(23)
Completed(36)
Terminated(17)
Other(24)

Detailed Status

Completed36
unknown22
Recruiting15
Terminated11
Withdrawn6
Active, not recruiting5

Development Timeline

Analytics

Development Status

Total Trials
100
Active
20
Success Rate
76.6%
Most Advanced
Phase 4

Trials by Phase

Early Phase 13 (4.7%)
Phase 13 (4.7%)
Phase 25 (7.8%)
Phase 41 (1.6%)
N/A52 (81.3%)

Trials by Status

not_yet_recruiting22%
suspended22%
unknown2222%
enrolling_by_invitation11%
terminated1111%
completed3636%
active_not_recruiting55%
withdrawn66%
recruiting1515%

Recent Activity

Clinical Trials (100)

Showing 20 of 100 trialsScroll for more
NCT07472491Phase 2

A Phase 2/3 Study on the Efficacy and Safety of Mangaciclanol for Contrast-Enhanced MRI of CNS or Body in Adult Patients

Recruiting
NCT07415018Not Applicable

Optimizing Contrast Dose and Scanning Parameters for Detection of Leptomeningeal Disease

Not Yet Recruiting
NCT04228172

Genotypic Influences on Network Progression in Parkinson's Disease

Active Not Recruiting
NCT04362540

Is Fat in the Liver a Marker of Post-Pregnancy Glycaemic Deterioration in Women With Gestational Diabetes?

Active Not Recruiting
NCT05595577Not Applicable

Improving Exercise Capacity With a Tailored Physical Activity Intervention

Recruiting
NCT06086366

Presynaptic Imaging in Major Depressive Episodes After COVID-19

Recruiting
NCT06636526

The i4i PRODICT® Study: Evaluation of the i4i PRODICT® Test in Different Ethnic Groups (The i4i PRODICT® Study).

Recruiting
NCT07384559Not Applicable

Exploratory Study Investigating the Urinary Bladder During Intermittent Catheterization in Healthy and Spinal Cord Injured Male and Female Subjects Using an Upright MRI Scanner

Not Yet Recruiting
NCT06648473Not Applicable

Repeatability of Magnetic Resonance Imaging in Patients With IDH1 Mutant Glioma on Ivosidenib

Withdrawn
NCT03500081

Solid Tumor Imaging MR-Linac (STIM Study)

Suspended
NCT02840019Not Applicable

Advanced Fetal Imaging - Phase II

Recruiting
NCT06199479Phase 1

Radiologic Pathologic Correlation of Imaging to Distinguish True Progression From Pseudoprogression in Brain Malignancies

Recruiting
NCT06101940

A Multicenter Phenotype-Genotype Analysis of DM1 Patients in China

Enrolling By Invitation
NCT05524012

Longitudinal Multimodal Response Assessment During Neoadjuvant Treatment of Rectal Cancer

Active Not Recruiting
NCT06236048

Energetics and Glutamate in Schizophrenia

Recruiting
NCT02791568

Advanced MRI for Uteroplacental Flow, Perfusion, Oxygenation & Inflammation

Completed
NCT04839185Early Phase 1

Placental Lesions in Fetal Growth Restrictions

Completed
NCT04871074Phase 2

The Synapse Project

Completed
NCT03302663Not Applicable

The Value of Advanced Imaging Sequences for Fetal MRI in Clinical Practice

Recruiting
NCT06212479

An Observational Study On TheAccuracy Of Whole-Body Magnetic Resonance Imaging (Wb-Mri) ScreeningTo Predict Clinically Significant Diagnoses In General Population Subjects Interested In Proactive And Advanced General Preventive Healthcare.

Recruiting

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
100